EXAI

- · NASDAQ

Sector -
Industry -
Website exscientia.ai
Employees(FY) 481
ISIN -

Performance

-4.35%

-5.1%

YTD

-22.62%

Profile

Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. It also focuses on discovery and development of small molecule drug candidates. The company's platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. Exscientia plc was founded in 2012 and is headquartered in Oxford, the United Kingdom.

Advanced Technical Analysis

Technical Analysis of EXAI 2024-11-19

The stock indicators reflect a predominantly bearish sentiment, with a Moving Average Score of 10 indicating strong downward momentum, an Oscillators Score of 43 suggesting a neutral stance, and a Technical Score of 26 reinforcing the overall bearish outlook. This combination signals caution for potential investors as the market appears to be st...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of EXAI

Stock Rank

Recent News & Updates

2024-11-20 07:00
Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery(GlobeNewswire)
2024-11-19 18:00
Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery(Globenewswire)
2024-11-13 09:47
Recursion Pharmaceuticals, Exscientia Shareholders Approve Proposed Combination(MT Newswires)
2024-11-12 20:08
Recursion and Exscientia Shareholders Approve the Proposed Combination(Globenewswire)
2024-10-17 07:11
Exscientia advances two additional discovery programs with Sanofi(TipRanks)
2024-10-16 07:39
Exscientia Expects $15 Million in Milestone Payments From Sanofi(MT Newswires)
2024-10-16 07:00
Exscientia Achieves Milestones for Two Programmes in Sanofi Collaboration(Business Wire)
2024-10-15 19:00
Exscientia Achieves Milestones for Two Programmes in Sanofi Collaboration(Businesswire)
2024-10-11 20:58
Recursion’s All-Stock Acquisition of Exscientia plc (EXAI): NVIDIA-Backed Merger to Revolutionize AI-Driven Drug Discovery(Insider Monkey)
2024-10-11 08:58
Recursion's All-Stock Acquisition of Exscientia plc (EXAI): NVIDIA-Backed Merger to Revolutionize AI-Driven Drug Discovery(Insidermonkey)
2024-10-11 06:28
Exscientia Set for Strategic Acquisition by Recursion(TipRanks)
2024-10-09 07:00
Exscientia to Present New Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ENA 2024(Business Wire)
2024-10-08 19:00
Exscientia to Present New Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ENA 2024(Businesswire)
2024-10-04 07:48
Harrow (HROW) Surges 8.4%: Is This an Indication of Further Gains?(Zacks)
2024-10-02 09:52
Exscientia outline robot and AI use in drug discovery workflow(Pharmaceutical Technology)
2024-09-23 21:00
AI Revolution in Healthcare Gains Momentum as FDA Prepares for Tech Boom(Prnewswire)
2024-09-08 04:51
Recursion Pharmaceuticals, Inc. (RXRX): Among the Worst ARK Stocks According to Short Sellers(Insidermonkey)
2024-08-31 14:09
Exscientia Plc (EXAI): A Penny Stock That Will Make You a Millionaire(Insider Monkey)
2024-08-31 02:09
Exscientia Plc (EXAI): A Penny Stock That Will Make You a Millionaire(Insidermonkey)
2024-08-28 07:00
Exscientia to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference(Business Wire)
2024-08-27 19:00
Exscientia to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference(Businesswire)
2024-08-18 12:34
The Bull Thesis for Recursion Pharmaceuticals Stock Just Got Stronger. Here's Why.(Motley Fool)
2024-08-16 14:22
News Flash: 4 Analysts Think Exscientia plc (NASDAQ:EXAI) Earnings Are Under Threat(Simply Wall St.)
2024-08-15 07:00
Exscientia Business Update for Second Quarter and First Half 2024(Business Wire)
2024-08-14 19:00
Exscientia Business Update for Second Quarter and First Half 2024(Businesswire)
2024-08-13 21:45
How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates(Globenewswire)
2024-08-11 04:59
Is Recursion Pharmaceuticals a Buy Ahead of Its Merger With Exscientia?(Motley Fool)
2024-08-09 04:32
Recursion and Exscientia merge to form drug discovery company(Pharmaceutical Technology)
2024-08-08 21:37
Recursion CEO on $688M Exscientia acquisition: Hope to bring better medicines to patients sooner(Youtube)
2024-08-08 17:37
AI-Powered Drug Discovery Firm Exscientia To Merge With Nvidia-Partner Recursion Pharmaceuticals(Benzinga)

Page 1 of 7

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.